Bioventix

Here is the public summary page for Bioventix. Please login to see the complete information for Bioventix including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Bioventix stacks up relative to its peers.


Darwin Score+2
TickerBVXP
Latest Price23.00 GBP as of close on 15-Aug-2025
3 Month price range23.00 to 30.20 GBP
Market Capitalisation125.14Mn GBP
CountryUK
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
See More ...
Company URLhttps://www.bioventix.com
See Darwins Full Analysis for Bioventix

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Bioventix. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages-10
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.+5
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+7

Alerts

There are 9 live alerts for Bioventix.


Peer Comparison

There are 29 peers of Bioventix.
Asset NameIndustry GroupPerf(20d)%Asset Score
4BASEBIO UK SOCIETAS (4BB)Biotechnology-8.6-14
Abingdon Health Plc (ABDX)Biotechnology0-25
Alliance Pharma plc (APH)Biotechnology+0.8+31
Angle PLC (AGL)Biotechnology-15.4-18
Aptamer Group PLC (APTA)Biotechnology+80.3+12
Arecor Therapeutics PLC (AREC)Biotechnology+29.6+6
Avacta Group PLC (AVCT)Biotechnology+47.7+16
BSF Enterprise Plc (BSFA)Biotechnology+1.2-16
Benchmark Holdings Plc (BMK)Biotechnology-10.7-18
Beximco Pharmaceuticals Limited (BXP)Biotechnology+20.3+32
BiVictriX Therapeutics PLC (BVX)Biotechnology+21.2+2
Celadon Pharmaceuticals PLC (CEL)Biotechnology0-8
Chill Brands Group PLC (CHLL)Biotechnology-2.3-21
Cizzle Biotechnology Holdings PLC (CIZ)Biotechnology-18.8-15
Destiny Pharma PLC (DEST)Biotechnology-7.7-30
Diaceutics PLC (DXRX)Biotechnology+7.0+17
Evgen Pharma PLC (EVG)Biotechnology-8.6-7
Faron Pharmaceuticals Oy (FARN)Biotechnology+2.4+12
Genflow Biosciences plc (GENF)Biotechnology-10.7-27
Genincode PLC (GENI)Biotechnology-26.3-21
Genus PLC (GNS)Biotechnology+8.3+20
Haleon PLC (HLN)Biotechnology0+4
Ondine Biomedical Inc (OBI)Biotechnology+25.0+14
Oxford BioMedica PLC (OXB)Biotechnology+33.6+41
Oxford Nanopore Technologies PLC (ONT)Biotechnology+43.5+8
Physiomics PLC (PYC)Biotechnology-10.5-9
Shield Therapeutics PLC (STX)Biotechnology+59.2+20
e-therapeutics plc (ETX)Biotechnology-28.0-4
genedrive plc (GDR)Biotechnology-39.3-8

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn